LakeShore Biopharma Ownership 2024 | Who Owns LakeShore Biopharma Now?
Institutional Ownership
0.00%
Insider Ownership
81.43%
Institutional Holders
13.00
LakeShore Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
HHLR ADVISORS, LTD. | - | 0.02% | 751,790 | 751,790 | 100.00% | 1,202,864,000 | Mar 31, 2023 |
SNOW LAKE MANAGEMENT LP | - | 1.72% | 1,811,942 | 1,811,942 | 100.00% | 2,899,107,000 | Mar 31, 2023 |
PINPOINT ASSET MANAGEMENT LTD | - | 0.00% | 50,000 | 50,000 | 100.00% | 7,785,000 | Mar 31, 2023 |
FLOW STATE INVESTMENTS, L.P. | - | 0.03% | 20,000 | 20,000 | 100.00% | 32,000,000 | Mar 31, 2023 |
ORBIMED ADVISORS LLC | - | 0.14% | 4,298,464 | 4,298,464 | 100.00% | 6,877,542,000 | Mar 31, 2023 |
FMR LLC | - | 0.00% | 1,165,071 | 1,165,071 | 100.00% | 1,864,114,000 | Mar 31, 2023 |
RTW INVESTMENTS, LP | - | 0.01% | 341,090 | 341,090 | 100.00% | 545,744,000 | Mar 31, 2023 |
FIL LTD | - | 0.01% | 2,718,499 | 2,718,499 | 100.00% | 4,349,598,000 | Mar 31, 2023 |
JANE STREET GROUP, LLC | - | - | 11,971 | 11,971 | 100.00% | 19,154,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | 13,608 | 13,608 | 100.00% | 21,772,000 | Mar 31, 2023 |
WOLVERINE ASSET MANAGEMENT LLC | - | - | 499 | 499 | 100.00% | 798,000 | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | 23,086 | 23,086 | 100.00% | 37,000 | Mar 31, 2023 |
VALLIANCE ASSET MANAGEMENT LTD | - | 4.59% | 1,607,175 | 1,607,175 | 100.00% | 2,571,480,000 | Mar 31, 2023 |
LakeShore Biopharma's largest institutional shareholder is HHLR ADVISORS, LTD., holding 0.00% of the company's total share outstanding, currently valued at $1.20B. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VALLIANCE ASSET MANAGEMENT LTD | - | 4.59% | 1,607,175 | 1,607,175 | 100.00% | 2,571,480,000 | Mar 31, 2023 |
SNOW LAKE MANAGEMENT LP | - | 1.72% | 1,811,942 | 1,811,942 | 100.00% | 2,899,107,000 | Mar 31, 2023 |
ORBIMED ADVISORS LLC | - | 0.14% | 4,298,464 | 4,298,464 | 100.00% | 6,877,542,000 | Mar 31, 2023 |
FLOW STATE INVESTMENTS, L.P. | - | 0.03% | 20,000 | 20,000 | 100.00% | 32,000,000 | Mar 31, 2023 |
HHLR ADVISORS, LTD. | - | 0.02% | 751,790 | 751,790 | 100.00% | 1,202,864,000 | Mar 31, 2023 |
RTW INVESTMENTS, LP | - | 0.01% | 341,090 | 341,090 | 100.00% | 545,744,000 | Mar 31, 2023 |
FIL LTD | - | 0.01% | 2,718,499 | 2,718,499 | 100.00% | 4,349,598,000 | Mar 31, 2023 |
PINPOINT ASSET MANAGEMENT LTD | - | 0.00% | 50,000 | 50,000 | 100.00% | 7,785,000 | Mar 31, 2023 |
FMR LLC | - | 0.00% | 1,165,071 | 1,165,071 | 100.00% | 1,864,114,000 | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | 23,086 | 23,086 | 100.00% | 37,000 | Mar 31, 2023 |
WOLVERINE ASSET MANAGEMENT LLC | - | - | 499 | 499 | 100.00% | 798,000 | Mar 31, 2023 |
JANE STREET GROUP, LLC | - | - | 11,971 | 11,971 | 100.00% | 19,154,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | 13,608 | 13,608 | 100.00% | 21,772,000 | Mar 31, 2023 |
The largest LakeShore Biopharma shareholder by % of total assets is VALLIANCE ASSET MANAGEMENT LTD. The company owns 1.61M shares of LakeShore Biopharma (YS), representing 4.59% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ORBIMED ADVISORS LLC | - | 0.14% | 4,298,464 | 4,298,464 | 100.00% | 6,877,542,000 | Mar 31, 2023 |
FIL LTD | - | 0.01% | 2,718,499 | 2,718,499 | 100.00% | 4,349,598,000 | Mar 31, 2023 |
SNOW LAKE MANAGEMENT LP | - | 1.72% | 1,811,942 | 1,811,942 | 100.00% | 2,899,107,000 | Mar 31, 2023 |
VALLIANCE ASSET MANAGEMENT LTD | - | 4.59% | 1,607,175 | 1,607,175 | 100.00% | 2,571,480,000 | Mar 31, 2023 |
FMR LLC | - | 0.00% | 1,165,071 | 1,165,071 | 100.00% | 1,864,114,000 | Mar 31, 2023 |
HHLR ADVISORS, LTD. | - | 0.02% | 751,790 | 751,790 | 100.00% | 1,202,864,000 | Mar 31, 2023 |
RTW INVESTMENTS, LP | - | 0.01% | 341,090 | 341,090 | 100.00% | 545,744,000 | Mar 31, 2023 |
PINPOINT ASSET MANAGEMENT LTD | - | 0.00% | 50,000 | 50,000 | 100.00% | 7,785,000 | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | 23,086 | 23,086 | 100.00% | 37,000 | Mar 31, 2023 |
FLOW STATE INVESTMENTS, L.P. | - | 0.03% | 20,000 | 20,000 | 100.00% | 32,000,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | 13,608 | 13,608 | 100.00% | 21,772,000 | Mar 31, 2023 |
JANE STREET GROUP, LLC | - | - | 11,971 | 11,971 | 100.00% | 19,154,000 | Mar 31, 2023 |
WOLVERINE ASSET MANAGEMENT LLC | - | - | 499 | 499 | 100.00% | 798,000 | Mar 31, 2023 |
As of Mar 31 2023, LakeShore Biopharma's largest institutional buyer is ORBIMED ADVISORS LLC. The company purchased 4.30M stocks of YS, valued at $6.88B.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WOLVERINE ASSET MANAGEMENT LLC | - | - | 499 | 499 | 100.00% | 798,000 | Mar 31, 2023 |
JANE STREET GROUP, LLC | - | - | 11,971 | 11,971 | 100.00% | 19,154,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | 13,608 | 13,608 | 100.00% | 21,772,000 | Mar 31, 2023 |
FLOW STATE INVESTMENTS, L.P. | - | 0.03% | 20,000 | 20,000 | 100.00% | 32,000,000 | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | 23,086 | 23,086 | 100.00% | 37,000 | Mar 31, 2023 |
PINPOINT ASSET MANAGEMENT LTD | - | 0.00% | 50,000 | 50,000 | 100.00% | 7,785,000 | Mar 31, 2023 |
RTW INVESTMENTS, LP | - | 0.01% | 341,090 | 341,090 | 100.00% | 545,744,000 | Mar 31, 2023 |
HHLR ADVISORS, LTD. | - | 0.02% | 751,790 | 751,790 | 100.00% | 1,202,864,000 | Mar 31, 2023 |
FMR LLC | - | 0.00% | 1,165,071 | 1,165,071 | 100.00% | 1,864,114,000 | Mar 31, 2023 |
VALLIANCE ASSET MANAGEMENT LTD | - | 4.59% | 1,607,175 | 1,607,175 | 100.00% | 2,571,480,000 | Mar 31, 2023 |
SNOW LAKE MANAGEMENT LP | - | 1.72% | 1,811,942 | 1,811,942 | 100.00% | 2,899,107,000 | Mar 31, 2023 |
FIL LTD | - | 0.01% | 2,718,499 | 2,718,499 | 100.00% | 4,349,598,000 | Mar 31, 2023 |
ORBIMED ADVISORS LLC | - | 0.14% | 4,298,464 | 4,298,464 | 100.00% | 6,877,542,000 | Mar 31, 2023 |
As of Mar 31 2023, LakeShore Biopharma's biggest institutional seller is WOLVERINE ASSET MANAGEMENT LLC. The company sold 499.00 shares of YS, valued at $798.00K.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ORBIMED ADVISORS LLC | - | 0.14% | 4,298,464 | 4,298,464 | 100.00% | 6,877,542,000 | Mar 31, 2023 |
FIL LTD | - | 0.01% | 2,718,499 | 2,718,499 | 100.00% | 4,349,598,000 | Mar 31, 2023 |
SNOW LAKE MANAGEMENT LP | - | 1.72% | 1,811,942 | 1,811,942 | 100.00% | 2,899,107,000 | Mar 31, 2023 |
VALLIANCE ASSET MANAGEMENT LTD | - | 4.59% | 1,607,175 | 1,607,175 | 100.00% | 2,571,480,000 | Mar 31, 2023 |
FMR LLC | - | 0.00% | 1,165,071 | 1,165,071 | 100.00% | 1,864,114,000 | Mar 31, 2023 |
HHLR ADVISORS, LTD. | - | 0.02% | 751,790 | 751,790 | 100.00% | 1,202,864,000 | Mar 31, 2023 |
RTW INVESTMENTS, LP | - | 0.01% | 341,090 | 341,090 | 100.00% | 545,744,000 | Mar 31, 2023 |
PINPOINT ASSET MANAGEMENT LTD | - | 0.00% | 50,000 | 50,000 | 100.00% | 7,785,000 | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | 23,086 | 23,086 | 100.00% | 37,000 | Mar 31, 2023 |
FLOW STATE INVESTMENTS, L.P. | - | 0.03% | 20,000 | 20,000 | 100.00% | 32,000,000 | Mar 31, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | 13,608 | 13,608 | 100.00% | 21,772,000 | Mar 31, 2023 |
JANE STREET GROUP, LLC | - | - | 11,971 | 11,971 | 100.00% | 19,154,000 | Mar 31, 2023 |
WOLVERINE ASSET MANAGEMENT LLC | - | - | 499 | 499 | 100.00% | 798,000 | Mar 31, 2023 |
LakeShore Biopharma's largest new institutional shareholder by number of shares is ORBIMED ADVISORS LLC, purchased 4.30M shares, valued at $6.88B, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
LakeShore Biopharma Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 23 | 13 | - |
As of 31 Mar 23, 13 institutions are holding LakeShore Biopharma's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 23 | 12,813,195 | - |
LakeShore Biopharma (YS) has 12.81M shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 23 | - | - |
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 23 | - | - |
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 23 | - | - |
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 23 | 13 | - | 12,813,195 | - | - | - | - | - | - | - |
LakeShore Biopharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of LakeShore Biopharma's stock was made by GLAZER CAPITAL, LLC on Dec 10 2020, selling 25,000 shares at $10.45 per share (valued at $261.25K). The last insider buy of YS was made by Rozek Alexander Buffett on Jan 27 2022, buying 4,500,000 shares at $10.00 per share (worth $45.00M).
LakeShore Biopharma Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|
LakeShore Biopharma Peer Ownership
Ticker | Company |
---|---|
ZVSA | ZyVersa Therapeutics, Inc. |
BDRX | Biodexa Pharmaceuticals Plc |
CNSP | CNS Pharmaceuticals, Inc. |
VIRI | Virios Therapeutics, Inc. |
REVB | Revelation Biosciences, Inc. |
QNRX | Quoin Pharmaceuticals, Ltd. |
VRAX | Virax Biolabs Group Limited |
EFTR | eFFECTOR Therapeutics, Inc. |
ALLR | Allarity Therapeutics, Inc. |
IMMX | Immix Biopharma, Inc. |
SONN | Sonnet BioTherapeutics Holdings, Inc. |
ZURA | Zura Bio Limited |
CDIO | Cardio Diagnostics Holdings, Inc. |
YS Ownership FAQ
Who Owns LakeShore Biopharma?
LakeShore Biopharma is owned by institutional shareholders (0%), insiders (81.43%), and public (0%). The largest institutional shareholder of LakeShore Biopharma is HHLR ADVISORS, LTD. (0% of total shares) and the top mutual fund owner is (0% of total shares).
Who are the major institutional shareholders of LakeShore Biopharma?
LakeShore Biopharma's major institutional shareholders are HHLR ADVISORS, LTD., SNOW LAKE MANAGEMENT LP, PINPOINT ASSET MANAGEMENT LTD, FLOW STATE INVESTMENTS, L.P., and ORBIMED ADVISORS LLC. The top five shareholders own together 0% of the company's share outstanding.
How many LakeShore Biopharma shareholders are there?
As of Mar 2023, there are 13 institutional shareholders of LakeShore Biopharma.
What percentage of LakeShore Biopharma is owned by HHLR ADVISORS, LTD?
HHLR ADVISORS, LTD owns 751.79K shares of LakeShore Biopharma, representing 0% of the company's total shares outstanding, valued at $1.2B (as of Mar 2023).
What percentage of LakeShore Biopharma is owned by SNOW LAKE MANAGEMENT LP?
As of Mar 2023, SNOW LAKE MANAGEMENT LP holds 1.81M shares of LakeShore Biopharma (YS), compromising 0% of the company, valued at $2.9B.
What percentage of LakeShore Biopharma is owned by PINPOINT ASSET MANAGEMENT LTD?
PINPOINT ASSET MANAGEMENT LTD is the third largest holder of LakeShore Biopharma. The company owns 50K of the company's shares outstanding (worth $7.78M).